Related references
Note: Only part of the references are listed.State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough
Melissa Bersanelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
Heinz Laeubli et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study
Melissa Bersanelli et al.
IMMUNOTHERAPY (2018)
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)
P. Pedrazzoli et al.
ANNALS OF ONCOLOGY (2014)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Clearance of influenza virus infections by T cells: risk of collateral damage?
M. L. B. Hillaire et al.
CURRENT OPINION IN VIROLOGY (2013)
Ipilimumab Increases Activated T Cells and Enhances Humoral Immunity in Patients With Advanced Melanoma
Jeffrey S. Weber et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Interference with Intraepithelial TNF-α Signaling Inhibits CD8+ T-Cell-Mediated Lung Injury in Influenza Infection
Anon Srikiatkhachorn et al.
VIRAL IMMUNOLOGY (2010)
Epidemiology and outcomes of serious influenza-related infections in the cancer population
CD Cooksley et al.
CANCER (2005)
Share Paper
